RT Journal Article
SR Electronic
T1 Clinical Characteristics of Recurrent-positive Coronavirus Disease 2019 after Curative Discharge: a retrospective analysis of 15 cases in Wuhan China
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.02.20144873
DO 10.1101/2020.07.02.20144873
A1 Chen, Lan
A1 Zhang, Zhen-Yu
A1 Zhang, Xiao-Bin
A1 Zhang, Su-Zhen
A1 Han, Qiu-Ying
A1 Feng, Zhi-Peng
A1 Fu, Jian-Guo
A1 Xiao, Xiong
A1 Chen, Hui-Min
A1 Liu, Li-Long
A1 Chen, Xian-Li
A1 Lan, Yu-Pei
A1 Zhong, De-Jin
A1 Hu, Lan
A1 Wang, Jun-Hui
A1 Yin, Zhen-Yu
YR 2020
UL http://medrxiv.org/content/early/2020/07/04/2020.07.02.20144873.abstract
AB In China, the patients with previously negative RT-PCR results again test positive during the post-discharge isolation period. We aimed to determine the clinical characteristics of these “recurrent-positive” patients. We retrospectively reviewed the data of 15 recurrent-positive patients and 107 control patients with non-recurrent, moderate COVID-19 treated in Wuhan, China. Clinical data and laboratory results were comparatively analyzed. We found that recurrent-positive patients had moderate disease. The rate of recurrent-positive disease in our hospital was 1.87%. Recurrent-positive patients were significantly younger (43(35-54) years) than control patients (60(43-69) years) (P=0.011). The early LOS (length of stay in hospital before recurrence) was significantly longer in recurrent-positive patients (36(34-45) days) than in control patients (15(7-30) days) (P =0.001). The time required for the first conversion of RT-PCR results from positive to negative was significantly longer in recurrent-positive patients (14(10-17) days) than in control patients (6(3-9) days) (P =0.011). Serum COVID-19 antibody levels were significantly lower in recurrent-positive patients than in control patients (IgM: 13.69 ± 4.38 vs. 68.10 ± 20.85 AU/mL, P = 0.015; IgG: 78.53 ± 9.30 vs. 147.85 ± 13.33 AU/mL, P < 0.0001). Recurrent-positive patients were younger than control patients. The early LOS (length of stay in hospital before recurrence) was significantly longer in recurrent-positive group than that in control group. COVID-19 IgM/IgG antibody levels were significantly lower in recurrent-positive group than those in control group, which might explain why the virus RNA RT-PCR was positive after the initial “clinical cure”(with three times of virus RNA RT-PCR negative). The virus might not be fully eliminated because of the lower IgG level and their later replicating might result in recurrent-positive virus RNA RT-PCR.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialChiCTR2000030054Funding StatementMedical and Health Key project of Xiamen(3502Z20191106) Project of Xiamen science and Technology Bureau(3502Z20194016)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Xiamen zhongshan hospital All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe corresponding author Zhen-Yu Yin are responsible for all data referred to in the manuscript.E-mail: yinzy{at}xmu.edu.cn